Palantir (PLTR) faces two significant negative developments.

Palantir (PLTR) faces two significant negative developments. On June 16, 2026, Bloomberg reported that the French security service is replacing Palantir with locally developed software (source). This represents a loss of a key government client and could set a precedent for other European agencies. Separately, the Financial Times published an article the same day questioning Palantir's claims about its NHS contract, stating they rely on just a few hospitals (source). This undermines the narrative of broad adoption in the UK healthcare system. Both events challenge Palantir's revenue growth and market credibility, likely pressuring the stock. The combination of a high-profile contract loss and scrutiny of a marquee deal signal growing headwinds for the company's European expansion.